NCT06971562

Brief Summary

Most burns in children are due to scalds and with proper dressings will heal on their own without the need for surgery such as skin grafting. Many current burn dressings contain silver which is felt to reduce the risk of infection. Unfortunately, when applied to burns, silver causes pain and may actually slow healing. The aim of this study is to compare the time it takes for less severe burns in children to heal when they are treated with two forms of the same dressing, one that contains silver and another that does not. In addition, we will check to see if there is a difference between dressings in terms of the risk of infection and the quality of the healed skin.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2017

Completed
8 years until next milestone

First Submitted

Initial submission to the registry

May 6, 2025

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 14, 2025

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

8 years

First QC Date

May 6, 2025

Last Update Submit

May 6, 2025

Conditions

Keywords

silverburn dressingre-epithelializationscarringinfection

Outcome Measures

Primary Outcomes (1)

  • Time-to-re-epithelialization

    Time (in days) for complete re-epithelialization of the burn to which the dressing was applied

    10-21 days

Secondary Outcomes (2)

  • Rate of infection

    3 months

  • Vancouver Scar Scale (VSS) score

    3 and 6 months post-injury

Study Arms (2)

Aquacel

ACTIVE COMPARATOR

Aquacel hydrocellulose-based dressing applied to partial thickness burns

Device: Aquacel

Aquacel AG

ACTIVE COMPARATOR

Aquacel AG is identical in base composition to Aquacel (ie a hydrocellulose-based wound dressing which adheres to the raw wound surface) but contains 1.2% cationic silver.

Device: Aquacel AG

Interventions

Hydrocellulose wound dressing containing 1.2% cationic silver

Aquacel AG
AquacelDEVICE

Hydrocellulose wound dressing

Aquacel

Eligibility Criteria

AgeUp to 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • \<16 years old
  • partial thickness thermal (scald, contact, fire) burns up to 25% TBSA on the trunk and extremities
  • presenting \< 72 hours after injury

You may not qualify if:

  • mixed burn pattern (combination of partial and full thickness burn) or full thickness burns requiring surgery at either anatomic sites.
  • isolated burns to perineum, hands, or feet allergy to silver
  • concomitant injury (eg.fractures)
  • inhalational injury
  • chemical burn
  • electrical burn
  • unable to understand English or French
  • have not had a silver-based wound dressing applied prior to presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IWK Health Centre

Halifax, Nova Scotia, B3K 6R8, Canada

Location

MeSH Terms

Conditions

CicatrixInfections

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Bezuhly, MD, MSc, SM, FRCSC

    IWK Health Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 6, 2025

First Posted

May 14, 2025

Study Start

May 3, 2017

Primary Completion

May 10, 2025

Study Completion

May 10, 2025

Last Updated

May 14, 2025

Record last verified: 2025-05

Locations